← All trials
NCT01944371
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2013
- Primary completion
- May 1, 2014
- Completion date
- May 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 30
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- University of California, San FranciscoLead sponsor
- AmFARCollaborator
- Monash UniversityOverall official - principal investigator
- University of California, San FranciscoOverall official - principal investigator
- Monash UniversityCollaborator
- National Institute of Allergy and Infectious Diseases (NIAID)Collaborator
- University of California, San FranciscoReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.